Secreted human Ro52 autoantibody proteomes express a restricted set of public clonotypes
dc.contributor.author | Arentz, Georgia | |
dc.contributor.author | Thurgood, Lauren Alexandra | |
dc.contributor.author | Lindop, Rhianna | |
dc.contributor.author | Chataway, Timothy Kennion | |
dc.contributor.author | Gordon, Thomas Paul | |
dc.date.accessioned | 2013-08-26T04:52:36Z | |
dc.date.available | 2013-08-26T04:52:36Z | |
dc.date.issued | Dec-12 | |
dc.date.issued | 2012-12-01 | |
dc.description | This article appeared in a journal published by Elsevier Ltd. Under Elsevier's copyright, mandated authors are not permitted to make work available in an institutional repository. | en |
dc.description.abstract | Long-lived secreted autoantibody responses in systemic autoimmunity are generally regarded to be polyclonal and to express a diverse B-cell repertoire. Here, we have used a proteomic approach based on de novo sequencing to determine the clonality and V region structures of human autoantibodies directed against a prototypic systemic autoantigen, Ro52 (TRIM21). Remarkably, anti-Ro52 autoantibodies from patients with primary Sjögren’s syndrome, systemic lupus erythematosus, systemic sclerosis or polymyositis were restricted to two IgG1 kappa clonotypes that migrated as a single species on isoelectric focusing; shared a common light chain paired with one of two closely-related heavy chains; and were public in unrelated patients. Targeted mass spectrometry using these uniquely mutated V region peptides as surrogates detected anti-Ro52 autoantibodies in human sera with high sensitivity and specificity compared with traditional ELISA. Mass spectrometry-based detection of specific autoantibody motifs provides a powerful new tool for analysis of humoral autoimmunity. | en |
dc.description.sponsorship | Australian National Health & Medical Research Council | en |
dc.identifier.citation | Arentz, G., Thurgood, L.A., Lindop, R., Chataway, T.K. and Gordon, T.P., 2012. Secreted human Ro52 autoantibody proteomes express a restricted set of public clonotypes. Journal of Autoimmunity, 39(4), 466-470. | en |
dc.identifier.doi | https://doi.org/10.1016/j.jaut.2012.07.003 | en |
dc.identifier.issn | 0896-8411 | |
dc.identifier.uri | http://hdl.handle.net/2328/27000 | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en |
dc.relation | http://purl.org/au-research/grants/nhmrc/595907 | |
dc.relation.grantnumber | NHMRC/595907 | |
dc.rights | Copyright 2012 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved. | |
dc.rights.holder | Elsevier Ltd. | |
dc.subject | Autoimmunity | |
dc.subject | Proteome | |
dc.subject | Autoantibodies | |
dc.title | Secreted human Ro52 autoantibody proteomes express a restricted set of public clonotypes | en_US |
dc.type | Article | en |
local.contributor.authorOrcidLookup | Thurgood, Lauren Alexandra: https://orcid.org/0000-0002-6183-2797 | en_US |